Populations receiving immunosuppressive therapy, such as tumor necrosis factor-alpha (TNF) antagonists, systemic corticosteroids, or immunosuppressive drug therapy following organ transplantation, are at the greatest risk for active tuberculosis. The gene discussed is TNF; the disease is tuberculosis.